{
  "directed": true,
  "graph": {
    "annotation_list": {
      "PublicationStatus": [
        "Preprint"
      ],
      "PublicationType": [
        "Research"
      ],
      "Section": [
        "Results"
      ]
    },
    "annotation_pattern": {
      "BioAssay": ".*"
    },
    "annotation_url": {},
    "document_metadata": {
      "authors": "Abish K",
      "contact": "abish@causalitybiomodels.com",
      "copyright": "Copyright Â© 2020 Fraunhofer Institute SCAI, All rights reserved",
      "description": "COVID Knowledge Curation project",
      "licenses": "Private Ownership to Fraunhofer Institute SCAI",
      "name": "Balasubramaniam_et.al_2020.bel",
      "version": "2.0.0"
    },
    "namespace_pattern": {
      "PUBCHEM": "^\\d+$"
    },
    "namespace_url": {
      "CHEBI": "https://arty.scai.fraunhofer.de/artifactory/bel/namespace/chebi/chebi-20190708.belns",
      "COVID": "https://arty.scai.fraunhofer.de/artifactory/bel/namespace/ncbi-covid19/ncbi-covid19-20200326.belns",
      "DO": "https://arty.scai.fraunhofer.de/artifactory/bel/namespace/disease-ontology/disease-ontology-20200407.belns",
      "GO": "https://arty.scai.fraunhofer.de/artifactory/bel/namespace/go/go-20180109.belns",
      "HGNC": "https://arty.scai.fraunhofer.de/artifactory/bel/namespace/hgnc/hgnc-20190708.belns",
      "MESH": "https://arty.scai.fraunhofer.de/artifactory/bel/namespace/mesh/mesh-names-20181007.belns",
      "TAX": "https://arty.scai.fraunhofer.de/artifactory/bel/namespace/ncbi-taxonomy/ncbi-taxonomy-20200322.belns"
    },
    "path": "Balasubramaniam_et.al_2020.bel",
    "pybel_version": "0.14.6"
  },
  "links": [
    {
      "annotations": {
        "BioAssay": {
          "molecular docking": true
        },
        "PublicationStatus": {
          "Preprint": true
        },
        "PublicationType": {
          "Research": true
        },
        "Section": {
          "Results": true
        }
      },
      "citation": {
        "db": "DOI",
        "db_id": "10.26434/chemrxiv.12084822.v2"
      },
      "evidence": "We selected three viral proteins that play essential roles in replication of the RNA genome of SARS-CoV-2: (1) RNA-dependent RNA polymerase (RdRP), (2) papain-like proteinase, and (3) helicase.",
      "key": "82513ce48db144b1052075d34701e7d8",
      "line": 46,
      "relation": "increases",
      "source": 29,
      "subject": {
        "modifier": "Activity"
      },
      "target": 10
    },
    {
      "key": "dffc7a631627994944652fc099d5f80e",
      "relation": "partOf",
      "source": 29,
      "target": 11
    },
    {
      "key": "980396fd1cb45bb4607f717a97cf4537",
      "relation": "partOf",
      "source": 29,
      "target": 13
    },
    {
      "key": "ec483ae9a08b969312c2abeace257706",
      "relation": "partOf",
      "source": 29,
      "target": 21
    },
    {
      "key": "f97e869387c1fdf87a36c211e6b2c297",
      "relation": "partOf",
      "source": 29,
      "target": 22
    },
    {
      "key": "6df6b30d5267f4cf2918f6e7c361d10d",
      "relation": "partOf",
      "source": 29,
      "target": 15
    },
    {
      "key": "b966125934da79e167d6aec08de4dc32",
      "relation": "partOf",
      "source": 29,
      "target": 25
    },
    {
      "key": "45c7b362d25cb0c8c9917948894eafbc",
      "relation": "hasVariant",
      "source": 27,
      "target": 29
    },
    {
      "key": "b7d33677a9029d0ceee889cfe902d83a",
      "relation": "hasVariant",
      "source": 27,
      "target": 32
    },
    {
      "key": "88b8e281f48e8f5e8ddd1948b2f197f9",
      "relation": "hasVariant",
      "source": 27,
      "target": 30
    },
    {
      "key": "635b99026a9147bc46e210ffcb130dcd",
      "relation": "hasVariant",
      "source": 27,
      "target": 31
    },
    {
      "key": "84a9f95a7d3b16f705d7150136b890fd",
      "relation": "hasVariant",
      "source": 27,
      "target": 28
    },
    {
      "annotations": {
        "BioAssay": {
          "molecular docking": true
        },
        "PublicationStatus": {
          "Preprint": true
        },
        "PublicationType": {
          "Research": true
        },
        "Section": {
          "Results": true
        }
      },
      "citation": {
        "db": "DOI",
        "db_id": "10.26434/chemrxiv.12084822.v2"
      },
      "evidence": "We selected three viral proteins that play essential roles in replication of the RNA genome of SARS-CoV-2: (1) RNA-dependent RNA polymerase (RdRP), (2) papain-like proteinase, and (3) helicase.",
      "key": "0d0a3c3246d06893594f1f795fa5e765",
      "line": 49,
      "relation": "association",
      "source": 10,
      "target": 8
    },
    {
      "annotations": {
        "BioAssay": {
          "molecular docking": true
        },
        "PublicationStatus": {
          "Preprint": true
        },
        "PublicationType": {
          "Research": true
        },
        "Section": {
          "Results": true
        }
      },
      "citation": {
        "db": "DOI",
        "db_id": "10.26434/chemrxiv.12084822.v2"
      },
      "evidence": "We selected three viral proteins that play essential roles in replication of the RNA genome of SARS-CoV-2: (1) RNA-dependent RNA polymerase (RdRP), (2) papain-like proteinase, and (3) helicase.",
      "key": "fe6c3ece8c2c3171d4c825d5346bfd9b",
      "line": 47,
      "relation": "increases",
      "source": 32,
      "subject": {
        "modifier": "Activity"
      },
      "target": 10
    },
    {
      "key": "2a4cdcee2827c88eba77bfaa0c5b7661",
      "relation": "partOf",
      "source": 32,
      "target": 18
    },
    {
      "key": "ea1d18fd521da7c1a715024c799f8597",
      "relation": "partOf",
      "source": 32,
      "target": 26
    },
    {
      "key": "d7ffd84ee00454500007eb54234a1201",
      "relation": "partOf",
      "source": 32,
      "target": 12
    },
    {
      "key": "a4356006828391a73ddf72bf6995db2d",
      "relation": "partOf",
      "source": 32,
      "target": 23
    },
    {
      "annotations": {
        "BioAssay": {
          "molecular docking": true
        },
        "PublicationStatus": {
          "Preprint": true
        },
        "PublicationType": {
          "Research": true
        },
        "Section": {
          "Results": true
        }
      },
      "citation": {
        "db": "DOI",
        "db_id": "10.26434/chemrxiv.12084822.v2"
      },
      "evidence": "We selected three viral proteins that play essential roles in replication of the RNA genome of SARS-CoV-2: (1) RNA-dependent RNA polymerase (RdRP), (2) papain-like proteinase, and (3) helicase.",
      "key": "a283a893346540dec3215c0060b1e87a",
      "line": 48,
      "relation": "increases",
      "source": 30,
      "subject": {
        "modifier": "Activity"
      },
      "target": 10
    },
    {
      "key": "a2b47ca46c6d04da9003643120890d21",
      "relation": "partOf",
      "source": 30,
      "target": 24
    },
    {
      "key": "7dd811205de0204c1bfcaa88ac2d7bcd",
      "relation": "partOf",
      "source": 30,
      "target": 16
    },
    {
      "annotations": {
        "BioAssay": {
          "molecular docking": true
        },
        "PublicationStatus": {
          "Preprint": true
        },
        "PublicationType": {
          "Research": true
        },
        "Section": {
          "Results": true
        }
      },
      "citation": {
        "db": "DOI",
        "db_id": "10.26434/chemrxiv.12084822.v2"
      },
      "evidence": "We selected three viral proteins that play essential roles in replication of the RNA genome of SARS-CoV-2: (1) RNA-dependent RNA polymerase (RdRP), (2) papain-like proteinase, and (3) helicase.",
      "key": "e6a35eb6447ee4def4e779530290fced",
      "line": 49,
      "relation": "association",
      "source": 8,
      "target": 10
    },
    {
      "annotations": {
        "BioAssay": {
          "molecular docking": true
        },
        "PublicationStatus": {
          "Preprint": true
        },
        "PublicationType": {
          "Research": true
        },
        "Section": {
          "Results": true
        }
      },
      "citation": {
        "db": "DOI",
        "db_id": "10.26434/chemrxiv.12084822.v2"
      },
      "evidence": "Other drugs predicted to have stable binding to RdRP include daclatasvir, delavirdine, ribavirin and sofosbuvir, but all showed lower affinity than elbasvir. We therefore focused on elbasvir as the most promising candidate for the RdRP target.",
      "key": "f42e15ea0774c56e475e23f3afd9859e",
      "line": 53,
      "object": {
        "modifier": "Activity"
      },
      "relation": "decreases",
      "source": 11,
      "target": 29
    },
    {
      "key": "ea34f6a47aa4d93be691b49c4f17bba3",
      "relation": "partOf",
      "source": 0,
      "target": 11
    },
    {
      "key": "6eb2175779e5b01495d329beadfd8de9",
      "relation": "partOf",
      "source": 0,
      "target": 12
    },
    {
      "annotations": {
        "BioAssay": {
          "molecular docking": true
        },
        "PublicationStatus": {
          "Preprint": true
        },
        "PublicationType": {
          "Research": true
        },
        "Section": {
          "Results": true
        }
      },
      "citation": {
        "db": "DOI",
        "db_id": "10.26434/chemrxiv.12084822.v2"
      },
      "evidence": "Other drugs predicted to have stable binding to RdRP include daclatasvir, delavirdine, ribavirin and sofosbuvir, but all showed lower affinity than elbasvir. We therefore focused on elbasvir as the most promising candidate for the RdRP target.",
      "key": "1634b02866a49ef8cda5c9e6f9cc7981",
      "line": 54,
      "object": {
        "modifier": "Activity"
      },
      "relation": "decreases",
      "source": 13,
      "target": 29
    },
    {
      "key": "2cdde59f190fb3327f46447b8011d67e",
      "relation": "partOf",
      "source": 1,
      "target": 13
    },
    {
      "annotations": {
        "BioAssay": {
          "molecular docking": true
        },
        "PublicationStatus": {
          "Preprint": true
        },
        "PublicationType": {
          "Research": true
        },
        "Section": {
          "Results": true
        }
      },
      "citation": {
        "db": "DOI",
        "db_id": "10.26434/chemrxiv.12084822.v2"
      },
      "evidence": "Other drugs predicted to have stable binding to RdRP include daclatasvir, delavirdine, ribavirin and sofosbuvir, but all showed lower affinity than elbasvir. We therefore focused on elbasvir as the most promising candidate for the RdRP target.",
      "key": "601d20da3fb025c3005f41863520c094",
      "line": 55,
      "object": {
        "modifier": "Activity"
      },
      "relation": "decreases",
      "source": 21,
      "target": 29
    },
    {
      "key": "0566e0ce0150da001eef1eefc281dcd6",
      "relation": "partOf",
      "source": 3,
      "target": 21
    },
    {
      "annotations": {
        "BioAssay": {
          "molecular docking": true
        },
        "PublicationStatus": {
          "Preprint": true
        },
        "PublicationType": {
          "Research": true
        },
        "Section": {
          "Results": true
        }
      },
      "citation": {
        "db": "DOI",
        "db_id": "10.26434/chemrxiv.12084822.v2"
      },
      "evidence": "Other drugs predicted to have stable binding to RdRP include daclatasvir, delavirdine, ribavirin and sofosbuvir, but all showed lower affinity than elbasvir. We therefore focused on elbasvir as the most promising candidate for the RdRP target.",
      "key": "e178ad61432e427d416997be2443a8a8",
      "line": 56,
      "object": {
        "modifier": "Activity"
      },
      "relation": "decreases",
      "source": 22,
      "target": 29
    },
    {
      "key": "cbe7d14b943a5fbce4bab1f936b322f3",
      "relation": "partOf",
      "source": 4,
      "target": 22
    },
    {
      "key": "935226130f3d94486b478766d2761608",
      "relation": "partOf",
      "source": 4,
      "target": 23
    },
    {
      "annotations": {
        "BioAssay": {
          "molecular docking": true
        },
        "PublicationStatus": {
          "Preprint": true
        },
        "PublicationType": {
          "Research": true
        },
        "Section": {
          "Results": true
        }
      },
      "citation": {
        "db": "DOI",
        "db_id": "10.26434/chemrxiv.12084822.v2"
      },
      "evidence": "Other drugs predicted to have stable binding to RdRP include daclatasvir, delavirdine, ribavirin and sofosbuvir, but all showed lower affinity than elbasvir. We therefore focused on elbasvir as the most promising candidate for the RdRP target.",
      "key": "ace995269f7c28e95cf75503dcf86d72",
      "line": 57,
      "object": {
        "modifier": "Activity"
      },
      "relation": "decreases",
      "source": 15,
      "target": 29
    },
    {
      "annotations": {
        "BioAssay": {
          "molecular docking": true
        },
        "PublicationStatus": {
          "Preprint": true
        },
        "PublicationType": {
          "Research": true
        },
        "Section": {
          "Results": true
        }
      },
      "citation": {
        "db": "DOI",
        "db_id": "10.26434/chemrxiv.12084822.v2"
      },
      "evidence": "Elbasvir is predicted to bind stably (ÎG â¤ â10.5) to RdRP, helicase, guanine-N7 methyltransferase, papain-like proteinase, proteinase SCL-PRO, and surface glycoprotein S, alone or in a complex with ACE2 (angiotensin converting enzyme 2), a host-cell protein exploited by SARS- CoV-2 for cell entry.",
      "key": "e94bab70c7c91a0b07fb8058134a0c8c",
      "line": 82,
      "object": {
        "modifier": "Activity"
      },
      "relation": "decreases",
      "source": 15,
      "target": 29
    },
    {
      "key": "2e418d20ff03aa3e33cc935ad29f2834",
      "relation": "partOf",
      "source": 2,
      "target": 15
    },
    {
      "key": "a4c50df5bc4220eedc6e14a4708d196b",
      "relation": "partOf",
      "source": 2,
      "target": 18
    },
    {
      "annotations": {
        "BioAssay": {
          "molecular docking": true
        },
        "PublicationStatus": {
          "Preprint": true
        },
        "PublicationType": {
          "Research": true
        },
        "Section": {
          "Results": true
        }
      },
      "citation": {
        "db": "DOI",
        "db_id": "10.26434/chemrxiv.12084822.v2"
      },
      "evidence": "We found that elbasvir blocked RNA binding, although RdRP readily bound RNA in the absence of a drug (Figure 5, a & b).",
      "key": "ba56d476f8b372ca400ab9713e1a0513",
      "line": 73,
      "relation": "decreases",
      "source": 2,
      "target": 25
    },
    {
      "annotations": {
        "BioAssay": {
          "molecular docking": true
        },
        "PublicationStatus": {
          "Preprint": true
        },
        "PublicationType": {
          "Research": true
        },
        "Section": {
          "Results": true
        }
      },
      "citation": {
        "db": "DOI",
        "db_id": "10.26434/chemrxiv.12084822.v2"
      },
      "evidence": "Elbasvir prevented helicase from binding to ssDNA, in contrast to stable binding in the absence of drug (Figure 5, c & d).",
      "key": "890e84b71d4a2348f5d9015d16e86e3d",
      "line": 78,
      "relation": "decreases",
      "source": 2,
      "target": 24
    },
    {
      "key": "f3b9cb984879a6d1de3f52cf3a13b7d3",
      "relation": "partOf",
      "source": 2,
      "target": 16
    },
    {
      "key": "165e89e7a46d84ad6a15ab137ac98fc4",
      "relation": "partOf",
      "source": 2,
      "target": 17
    },
    {
      "key": "0ff9926091d70b68548b1da617d2f797",
      "relation": "partOf",
      "source": 2,
      "target": 14
    },
    {
      "key": "72e76247c5397a6789697c3bb47de6ba",
      "relation": "partOf",
      "source": 2,
      "target": 19
    },
    {
      "key": "3b0fd08bb25120f2096f715dde180ec0",
      "relation": "partOf",
      "source": 2,
      "target": 20
    },
    {
      "annotations": {
        "BioAssay": {
          "molecular docking": true
        },
        "PublicationStatus": {
          "Preprint": true
        },
        "PublicationType": {
          "Research": true
        },
        "Section": {
          "Results": true
        }
      },
      "citation": {
        "db": "DOI",
        "db_id": "10.26434/chemrxiv.12084822.v2"
      },
      "evidence": "Elbasvir showed the most stable binding to protease in solvent-based MMGBSA estimation of ÎG, the free energy of binding (Figure 3c).",
      "key": "fd1316751c7e46062c23c42c61ebc1f1",
      "line": 61,
      "object": {
        "modifier": "Activity"
      },
      "relation": "decreases",
      "source": 18,
      "target": 32
    },
    {
      "annotations": {
        "BioAssay": {
          "molecular docking": true
        },
        "PublicationStatus": {
          "Preprint": true
        },
        "PublicationType": {
          "Research": true
        },
        "Section": {
          "Results": true
        }
      },
      "citation": {
        "db": "DOI",
        "db_id": "10.26434/chemrxiv.12084822.v2"
      },
      "evidence": "Elbasvir is predicted to bind stably (ÎG â¤ â10.5) to RdRP, helicase, guanine-N7 methyltransferase, papain-like proteinase, proteinase SCL-PRO, and surface glycoprotein S, alone or in a complex with ACE2 (angiotensin converting enzyme 2), a host-cell protein exploited by SARS- CoV-2 for cell entry.",
      "key": "c11665755fdcec8ce99b20d0fafaf80b",
      "line": 85,
      "object": {
        "modifier": "Activity"
      },
      "relation": "decreases",
      "source": 18,
      "target": 32
    },
    {
      "annotations": {
        "BioAssay": {
          "molecular docking": true
        },
        "PublicationStatus": {
          "Preprint": true
        },
        "PublicationType": {
          "Research": true
        },
        "Section": {
          "Results": true
        }
      },
      "citation": {
        "db": "DOI",
        "db_id": "10.26434/chemrxiv.12084822.v2"
      },
      "evidence": "Other drugs, including voxilaprevir, daclatasvir and sofosbuvir (Figure 3c), bound with lower stability (higher ÎG) than elbasvir.",
      "key": "849f149ee8e9de7cb09a1fd7305ca4e5",
      "line": 65,
      "object": {
        "modifier": "Activity"
      },
      "relation": "decreases",
      "source": 26,
      "target": 32
    },
    {
      "key": "ed0217c5d2621b9c273024aa70e965d0",
      "relation": "partOf",
      "source": 7,
      "target": 26
    },
    {
      "annotations": {
        "BioAssay": {
          "molecular docking": true
        },
        "PublicationStatus": {
          "Preprint": true
        },
        "PublicationType": {
          "Research": true
        },
        "Section": {
          "Results": true
        }
      },
      "citation": {
        "db": "DOI",
        "db_id": "10.26434/chemrxiv.12084822.v2"
      },
      "evidence": "Other drugs, including voxilaprevir, daclatasvir and sofosbuvir (Figure 3c), bound with lower stability (higher ÎG) than elbasvir.",
      "key": "df24817c11c1c9d66475b06df958fb45",
      "line": 66,
      "object": {
        "modifier": "Activity"
      },
      "relation": "decreases",
      "source": 12,
      "target": 32
    },
    {
      "annotations": {
        "BioAssay": {
          "molecular docking": true
        },
        "PublicationStatus": {
          "Preprint": true
        },
        "PublicationType": {
          "Research": true
        },
        "Section": {
          "Results": true
        }
      },
      "citation": {
        "db": "DOI",
        "db_id": "10.26434/chemrxiv.12084822.v2"
      },
      "evidence": "Other drugs, including voxilaprevir, daclatasvir and sofosbuvir (Figure 3c), bound with lower stability (higher ÎG) than elbasvir.",
      "key": "7b1fa430e1d93d6784fe07fc66455651",
      "line": 67,
      "object": {
        "modifier": "Activity"
      },
      "relation": "decreases",
      "source": 23,
      "target": 32
    },
    {
      "annotations": {
        "BioAssay": {
          "molecular docking": true
        },
        "PublicationStatus": {
          "Preprint": true
        },
        "PublicationType": {
          "Research": true
        },
        "Section": {
          "Results": true
        }
      },
      "citation": {
        "db": "DOI",
        "db_id": "10.26434/chemrxiv.12084822.v2"
      },
      "evidence": "We found that elbasvir blocked RNA binding, although RdRP readily bound RNA in the absence of a drug (Figure 5, a & b).",
      "key": "89a3737f932414d261e00798f6606887",
      "line": 74,
      "relation": "increases",
      "source": 25,
      "target": 10
    },
    {
      "key": "637b7ecbef604360865e2f9b58d15031",
      "relation": "partOf",
      "source": 6,
      "target": 25
    },
    {
      "key": "8700b3bac9382d40766f8bf7e1f8811b",
      "relation": "partOf",
      "source": 5,
      "target": 24
    },
    {
      "annotations": {
        "BioAssay": {
          "molecular docking": true
        },
        "PublicationStatus": {
          "Preprint": true
        },
        "PublicationType": {
          "Research": true
        },
        "Section": {
          "Results": true
        }
      },
      "citation": {
        "db": "DOI",
        "db_id": "10.26434/chemrxiv.12084822.v2"
      },
      "evidence": "Elbasvir is predicted to bind stably (ÎG â¤ â10.5) to RdRP, helicase, guanine-N7 methyltransferase, papain-like proteinase, proteinase SCL-PRO, and surface glycoprotein S, alone or in a complex with ACE2 (angiotensin converting enzyme 2), a host-cell protein exploited by SARS- CoV-2 for cell entry.",
      "key": "6688023615d1497e4f20680a4200a37f",
      "line": 83,
      "object": {
        "modifier": "Activity"
      },
      "relation": "decreases",
      "source": 16,
      "target": 30
    },
    {
      "annotations": {
        "BioAssay": {
          "molecular docking": true
        },
        "PublicationStatus": {
          "Preprint": true
        },
        "PublicationType": {
          "Research": true
        },
        "Section": {
          "Results": true
        }
      },
      "citation": {
        "db": "DOI",
        "db_id": "10.26434/chemrxiv.12084822.v2"
      },
      "evidence": "Elbasvir is predicted to bind stably (ÎG â¤ â10.5) to RdRP, helicase, guanine-N7 methyltransferase, papain-like proteinase, proteinase SCL-PRO, and surface glycoprotein S, alone or in a complex with ACE2 (angiotensin converting enzyme 2), a host-cell protein exploited by SARS- CoV-2 for cell entry.",
      "key": "2884b1f314cca06b4ca276dbc339f95d",
      "line": 84,
      "object": {
        "modifier": "Activity"
      },
      "relation": "decreases",
      "source": 17,
      "target": 31
    },
    {
      "key": "556633ab7ecf00b9fcb56b4c8b0daa87",
      "relation": "partOf",
      "source": 31,
      "target": 17
    },
    {
      "annotations": {
        "BioAssay": {
          "molecular docking": true
        },
        "PublicationStatus": {
          "Preprint": true
        },
        "PublicationType": {
          "Research": true
        },
        "Section": {
          "Results": true
        }
      },
      "citation": {
        "db": "DOI",
        "db_id": "10.26434/chemrxiv.12084822.v2"
      },
      "evidence": "Elbasvir is predicted to bind stably (ÎG â¤ â10.5) to RdRP, helicase, guanine-N7 methyltransferase, papain-like proteinase, proteinase SCL-PRO, and surface glycoprotein S, alone or in a complex with ACE2 (angiotensin converting enzyme 2), a host-cell protein exploited by SARS- CoV-2 for cell entry.",
      "key": "2f2c75a5d961553924d8853021a5dbf4",
      "line": 86,
      "object": {
        "modifier": "Activity"
      },
      "relation": "decreases",
      "source": 14,
      "target": 28
    },
    {
      "key": "6e43b7df92aa051954e627d400949ffe",
      "relation": "partOf",
      "source": 28,
      "target": 14
    },
    {
      "annotations": {
        "BioAssay": {
          "molecular docking": true
        },
        "PublicationStatus": {
          "Preprint": true
        },
        "PublicationType": {
          "Research": true
        },
        "Section": {
          "Results": true
        }
      },
      "citation": {
        "db": "DOI",
        "db_id": "10.26434/chemrxiv.12084822.v2"
      },
      "evidence": "Elbasvir is predicted to bind stably (ÎG â¤ â10.5) to RdRP, helicase, guanine-N7 methyltransferase, papain-like proteinase, proteinase SCL-PRO, and surface glycoprotein S, alone or in a complex with ACE2 (angiotensin converting enzyme 2), a host-cell protein exploited by SARS- CoV-2 for cell entry.",
      "key": "6224cb1120f9c60294847d56346ff361",
      "line": 87,
      "relation": "decreases",
      "source": 19,
      "target": 9
    },
    {
      "key": "3acb38abc24469eda79b2dd18086f90c",
      "relation": "partOf",
      "source": 33,
      "target": 19
    },
    {
      "key": "ab769a4be66e27eb8fcbfa5de3968535",
      "relation": "partOf",
      "source": 33,
      "target": 20
    },
    {
      "annotations": {
        "BioAssay": {
          "molecular docking": true
        },
        "PublicationStatus": {
          "Preprint": true
        },
        "PublicationType": {
          "Research": true
        },
        "Section": {
          "Results": true
        }
      },
      "citation": {
        "db": "DOI",
        "db_id": "10.26434/chemrxiv.12084822.v2"
      },
      "evidence": "Elbasvir is predicted to bind stably (ÎG â¤ â10.5) to RdRP, helicase, guanine-N7 methyltransferase, papain-like proteinase, proteinase SCL-PRO, and surface glycoprotein S, alone or in a complex with ACE2 (angiotensin converting enzyme 2), a host-cell protein exploited by SARS- CoV-2 for cell entry.",
      "key": "0e5f4fa52907997e110345da323ed91b",
      "line": 89,
      "relation": "increases",
      "source": 9,
      "target": 35
    },
    {
      "annotations": {
        "BioAssay": {
          "molecular docking": true
        },
        "PublicationStatus": {
          "Preprint": true
        },
        "PublicationType": {
          "Research": true
        },
        "Section": {
          "Results": true
        }
      },
      "citation": {
        "db": "DOI",
        "db_id": "10.26434/chemrxiv.12084822.v2"
      },
      "evidence": "Elbasvir is predicted to bind stably (ÎG â¤ â10.5) to RdRP, helicase, guanine-N7 methyltransferase, papain-like proteinase, proteinase SCL-PRO, and surface glycoprotein S, alone or in a complex with ACE2 (angiotensin converting enzyme 2), a host-cell protein exploited by SARS- CoV-2 for cell entry.",
      "key": "98114c55459fb0a8f7bbf546c7712919",
      "line": 88,
      "relation": "decreases",
      "source": 20,
      "target": 9
    },
    {
      "key": "4667ad0e1cac99892949891f2785aac8",
      "relation": "partOf",
      "source": 34,
      "target": 20
    }
  ],
  "multigraph": true,
  "nodes": [
    {
      "bel": "a(CHEBI:daclatasvir)",
      "concept": {
        "name": "daclatasvir",
        "namespace": "CHEBI"
      },
      "function": "Abundance",
      "id": "cac8e496037927d43744982299b10cc0"
    },
    {
      "bel": "a(CHEBI:delavirdine)",
      "concept": {
        "name": "delavirdine",
        "namespace": "CHEBI"
      },
      "function": "Abundance",
      "id": "b057a040846dda392d42641925a311ca"
    },
    {
      "bel": "a(CHEBI:elbasvir)",
      "concept": {
        "name": "elbasvir",
        "namespace": "CHEBI"
      },
      "function": "Abundance",
      "id": "99bce2a5493fbd5aaa62a3341d878fd8"
    },
    {
      "bel": "a(CHEBI:ribavirin)",
      "concept": {
        "name": "ribavirin",
        "namespace": "CHEBI"
      },
      "function": "Abundance",
      "id": "c126fb0a90c3749d6b1418b349632dcb"
    },
    {
      "bel": "a(CHEBI:sofosbuvir)",
      "concept": {
        "name": "sofosbuvir",
        "namespace": "CHEBI"
      },
      "function": "Abundance",
      "id": "a2f4db2c19412499301e5ceef21293a7"
    },
    {
      "bel": "a(GO:\"DNA viral genome\")",
      "concept": {
        "name": "DNA viral genome",
        "namespace": "GO"
      },
      "function": "Abundance",
      "id": "c8b243870c3df17a2f60902765305881"
    },
    {
      "bel": "a(GO:\"RNA viral genome\")",
      "concept": {
        "name": "RNA viral genome",
        "namespace": "GO"
      },
      "function": "Abundance",
      "id": "58886676a15d0caee20d11c6dbfcfc7d"
    },
    {
      "bel": "a(PUBCHEM:89921642)",
      "concept": {
        "name": "89921642",
        "namespace": "PUBCHEM"
      },
      "function": "Abundance",
      "id": "0b66e9d18aa721f07c3f718726f6f911"
    },
    {
      "bel": "a(TAX:\"Severe acute respiratory syndrome coronavirus 2\")",
      "concept": {
        "name": "Severe acute respiratory syndrome coronavirus 2",
        "namespace": "TAX"
      },
      "function": "Abundance",
      "id": "c41851da59cc36c21b2e8acf24c1f46d"
    },
    {
      "bel": "bp(GO:\"viral entry into host cell\")",
      "concept": {
        "name": "viral entry into host cell",
        "namespace": "GO"
      },
      "function": "BiologicalProcess",
      "id": "2a6e5ae8582e2cded25095e14c2ee329"
    },
    {
      "bel": "bp(MESH:\"Virus Replication\")",
      "concept": {
        "name": "Virus Replication",
        "namespace": "MESH"
      },
      "function": "BiologicalProcess",
      "id": "f511c0a55a7b8aa880279fba6181fd8c"
    },
    {
      "bel": "complex(a(CHEBI:daclatasvir), p(COVID:ORF1ab, frag(\"4393_5324\")))",
      "function": "Complex",
      "id": "f4e3731831c8182c7584e028ca76a695",
      "members": [
        {
          "bel": "a(CHEBI:daclatasvir)",
          "concept": {
            "name": "daclatasvir",
            "namespace": "CHEBI"
          },
          "function": "Abundance",
          "id": "cac8e496037927d43744982299b10cc0"
        },
        {
          "bel": "p(COVID:ORF1ab, frag(\"4393_5324\"))",
          "concept": {
            "name": "ORF1ab",
            "namespace": "COVID"
          },
          "function": "Protein",
          "id": "fd839a98b05d17327ddef0cb687a4b04",
          "variants": [
            {
              "kind": "frag",
              "start": 4393,
              "stop": 5324
            }
          ]
        }
      ]
    },
    {
      "bel": "complex(a(CHEBI:daclatasvir), p(COVID:ORF1ab, frag(\"819_2763\")))",
      "function": "Complex",
      "id": "31fcd83c035bb06b005329f08f1f42b1",
      "members": [
        {
          "bel": "a(CHEBI:daclatasvir)",
          "concept": {
            "name": "daclatasvir",
            "namespace": "CHEBI"
          },
          "function": "Abundance",
          "id": "cac8e496037927d43744982299b10cc0"
        },
        {
          "bel": "p(COVID:ORF1ab, frag(\"819_2763\"))",
          "concept": {
            "name": "ORF1ab",
            "namespace": "COVID"
          },
          "function": "Protein",
          "id": "598b8d5f87bf878c033f8fe9152ffb2b",
          "variants": [
            {
              "kind": "frag",
              "start": 819,
              "stop": 2763
            }
          ]
        }
      ]
    },
    {
      "bel": "complex(a(CHEBI:delavirdine), p(COVID:ORF1ab, frag(\"4393_5324\")))",
      "function": "Complex",
      "id": "d817ab16c11d85a972108b943f86b913",
      "members": [
        {
          "bel": "a(CHEBI:delavirdine)",
          "concept": {
            "name": "delavirdine",
            "namespace": "CHEBI"
          },
          "function": "Abundance",
          "id": "b057a040846dda392d42641925a311ca"
        },
        {
          "bel": "p(COVID:ORF1ab, frag(\"4393_5324\"))",
          "concept": {
            "name": "ORF1ab",
            "namespace": "COVID"
          },
          "function": "Protein",
          "id": "fd839a98b05d17327ddef0cb687a4b04",
          "variants": [
            {
              "kind": "frag",
              "start": 4393,
              "stop": 5324
            }
          ]
        }
      ]
    },
    {
      "bel": "complex(a(CHEBI:elbasvir), p(COVID:ORF1ab, frag(\"3264_3569\")))",
      "function": "Complex",
      "id": "308a401f7fae783e761c7172bcf35bac",
      "members": [
        {
          "bel": "a(CHEBI:elbasvir)",
          "concept": {
            "name": "elbasvir",
            "namespace": "CHEBI"
          },
          "function": "Abundance",
          "id": "99bce2a5493fbd5aaa62a3341d878fd8"
        },
        {
          "bel": "p(COVID:ORF1ab, frag(\"3264_3569\"))",
          "concept": {
            "name": "ORF1ab",
            "namespace": "COVID"
          },
          "function": "Protein",
          "id": "8b1aed13f6853876f8b68f28deac1a26",
          "variants": [
            {
              "kind": "frag",
              "start": 3264,
              "stop": 3569
            }
          ]
        }
      ]
    },
    {
      "bel": "complex(a(CHEBI:elbasvir), p(COVID:ORF1ab, frag(\"4393_5324\")))",
      "function": "Complex",
      "id": "d1a97cbc7cfe51e0cad343ce71e08542",
      "members": [
        {
          "bel": "a(CHEBI:elbasvir)",
          "concept": {
            "name": "elbasvir",
            "namespace": "CHEBI"
          },
          "function": "Abundance",
          "id": "99bce2a5493fbd5aaa62a3341d878fd8"
        },
        {
          "bel": "p(COVID:ORF1ab, frag(\"4393_5324\"))",
          "concept": {
            "name": "ORF1ab",
            "namespace": "COVID"
          },
          "function": "Protein",
          "id": "fd839a98b05d17327ddef0cb687a4b04",
          "variants": [
            {
              "kind": "frag",
              "start": 4393,
              "stop": 5324
            }
          ]
        }
      ]
    },
    {
      "bel": "complex(a(CHEBI:elbasvir), p(COVID:ORF1ab, frag(\"5325_5925\")))",
      "function": "Complex",
      "id": "88acd2608e4f40de5207c3a472a3a69c",
      "members": [
        {
          "bel": "a(CHEBI:elbasvir)",
          "concept": {
            "name": "elbasvir",
            "namespace": "CHEBI"
          },
          "function": "Abundance",
          "id": "99bce2a5493fbd5aaa62a3341d878fd8"
        },
        {
          "bel": "p(COVID:ORF1ab, frag(\"5325_5925\"))",
          "concept": {
            "name": "ORF1ab",
            "namespace": "COVID"
          },
          "function": "Protein",
          "id": "99748bbd1c3dda5cfe8a62029f894ba9",
          "variants": [
            {
              "kind": "frag",
              "start": 5325,
              "stop": 5925
            }
          ]
        }
      ]
    },
    {
      "bel": "complex(a(CHEBI:elbasvir), p(COVID:ORF1ab, frag(\"6799_7096\")))",
      "function": "Complex",
      "id": "6b59d9b0c917cc2137a91d39365c40a8",
      "members": [
        {
          "bel": "a(CHEBI:elbasvir)",
          "concept": {
            "name": "elbasvir",
            "namespace": "CHEBI"
          },
          "function": "Abundance",
          "id": "99bce2a5493fbd5aaa62a3341d878fd8"
        },
        {
          "bel": "p(COVID:ORF1ab, frag(\"6799_7096\"))",
          "concept": {
            "name": "ORF1ab",
            "namespace": "COVID"
          },
          "function": "Protein",
          "id": "4a61eef55307c856456e953e5ef84207",
          "variants": [
            {
              "kind": "frag",
              "start": 6799,
              "stop": 7096
            }
          ]
        }
      ]
    },
    {
      "bel": "complex(a(CHEBI:elbasvir), p(COVID:ORF1ab, frag(\"819_2763\")))",
      "function": "Complex",
      "id": "611148ef81e0907982539f993d33dcb2",
      "members": [
        {
          "bel": "a(CHEBI:elbasvir)",
          "concept": {
            "name": "elbasvir",
            "namespace": "CHEBI"
          },
          "function": "Abundance",
          "id": "99bce2a5493fbd5aaa62a3341d878fd8"
        },
        {
          "bel": "p(COVID:ORF1ab, frag(\"819_2763\"))",
          "concept": {
            "name": "ORF1ab",
            "namespace": "COVID"
          },
          "function": "Protein",
          "id": "598b8d5f87bf878c033f8fe9152ffb2b",
          "variants": [
            {
              "kind": "frag",
              "start": 819,
              "stop": 2763
            }
          ]
        }
      ]
    },
    {
      "bel": "complex(a(CHEBI:elbasvir), p(COVID:S))",
      "function": "Complex",
      "id": "c56789dc86961f909609e4476010c839",
      "members": [
        {
          "bel": "a(CHEBI:elbasvir)",
          "concept": {
            "name": "elbasvir",
            "namespace": "CHEBI"
          },
          "function": "Abundance",
          "id": "99bce2a5493fbd5aaa62a3341d878fd8"
        },
        {
          "bel": "p(COVID:S)",
          "concept": {
            "name": "S",
            "namespace": "COVID"
          },
          "function": "Protein",
          "id": "8d090715298e11996081058536798c19"
        }
      ]
    },
    {
      "bel": "complex(a(CHEBI:elbasvir), p(COVID:S), p(HGNC:ACE2))",
      "function": "Complex",
      "id": "ee0dc9b635310daaebe4b372ded50df9",
      "members": [
        {
          "bel": "a(CHEBI:elbasvir)",
          "concept": {
            "name": "elbasvir",
            "namespace": "CHEBI"
          },
          "function": "Abundance",
          "id": "99bce2a5493fbd5aaa62a3341d878fd8"
        },
        {
          "bel": "p(COVID:S)",
          "concept": {
            "name": "S",
            "namespace": "COVID"
          },
          "function": "Protein",
          "id": "8d090715298e11996081058536798c19"
        },
        {
          "bel": "p(HGNC:ACE2)",
          "concept": {
            "name": "ACE2",
            "namespace": "HGNC"
          },
          "function": "Protein",
          "id": "bb9a231a2c68ff8f3bad2adad9ed6a94"
        }
      ]
    },
    {
      "bel": "complex(a(CHEBI:ribavirin), p(COVID:ORF1ab, frag(\"4393_5324\")))",
      "function": "Complex",
      "id": "27babbadef85021001406e445eceae86",
      "members": [
        {
          "bel": "a(CHEBI:ribavirin)",
          "concept": {
            "name": "ribavirin",
            "namespace": "CHEBI"
          },
          "function": "Abundance",
          "id": "c126fb0a90c3749d6b1418b349632dcb"
        },
        {
          "bel": "p(COVID:ORF1ab, frag(\"4393_5324\"))",
          "concept": {
            "name": "ORF1ab",
            "namespace": "COVID"
          },
          "function": "Protein",
          "id": "fd839a98b05d17327ddef0cb687a4b04",
          "variants": [
            {
              "kind": "frag",
              "start": 4393,
              "stop": 5324
            }
          ]
        }
      ]
    },
    {
      "bel": "complex(a(CHEBI:sofosbuvir), p(COVID:ORF1ab, frag(\"4393_5324\")))",
      "function": "Complex",
      "id": "d28157b3934e5089dd6609735c7fa4f5",
      "members": [
        {
          "bel": "a(CHEBI:sofosbuvir)",
          "concept": {
            "name": "sofosbuvir",
            "namespace": "CHEBI"
          },
          "function": "Abundance",
          "id": "a2f4db2c19412499301e5ceef21293a7"
        },
        {
          "bel": "p(COVID:ORF1ab, frag(\"4393_5324\"))",
          "concept": {
            "name": "ORF1ab",
            "namespace": "COVID"
          },
          "function": "Protein",
          "id": "fd839a98b05d17327ddef0cb687a4b04",
          "variants": [
            {
              "kind": "frag",
              "start": 4393,
              "stop": 5324
            }
          ]
        }
      ]
    },
    {
      "bel": "complex(a(CHEBI:sofosbuvir), p(COVID:ORF1ab, frag(\"819_2763\")))",
      "function": "Complex",
      "id": "c351946e15576cc921b05190874df68f",
      "members": [
        {
          "bel": "a(CHEBI:sofosbuvir)",
          "concept": {
            "name": "sofosbuvir",
            "namespace": "CHEBI"
          },
          "function": "Abundance",
          "id": "a2f4db2c19412499301e5ceef21293a7"
        },
        {
          "bel": "p(COVID:ORF1ab, frag(\"819_2763\"))",
          "concept": {
            "name": "ORF1ab",
            "namespace": "COVID"
          },
          "function": "Protein",
          "id": "598b8d5f87bf878c033f8fe9152ffb2b",
          "variants": [
            {
              "kind": "frag",
              "start": 819,
              "stop": 2763
            }
          ]
        }
      ]
    },
    {
      "bel": "complex(a(GO:\"DNA viral genome\"), p(COVID:ORF1ab, frag(\"5325_5925\")))",
      "function": "Complex",
      "id": "4b83d583af24dc6955a2f556b4e4010d",
      "members": [
        {
          "bel": "a(GO:\"DNA viral genome\")",
          "concept": {
            "name": "DNA viral genome",
            "namespace": "GO"
          },
          "function": "Abundance",
          "id": "c8b243870c3df17a2f60902765305881"
        },
        {
          "bel": "p(COVID:ORF1ab, frag(\"5325_5925\"))",
          "concept": {
            "name": "ORF1ab",
            "namespace": "COVID"
          },
          "function": "Protein",
          "id": "99748bbd1c3dda5cfe8a62029f894ba9",
          "variants": [
            {
              "kind": "frag",
              "start": 5325,
              "stop": 5925
            }
          ]
        }
      ]
    },
    {
      "bel": "complex(a(GO:\"RNA viral genome\"), p(COVID:ORF1ab, frag(\"4393_5324\")))",
      "function": "Complex",
      "id": "d8bbf6b7ec8fc178a8fb09e3bcda27a5",
      "members": [
        {
          "bel": "a(GO:\"RNA viral genome\")",
          "concept": {
            "name": "RNA viral genome",
            "namespace": "GO"
          },
          "function": "Abundance",
          "id": "58886676a15d0caee20d11c6dbfcfc7d"
        },
        {
          "bel": "p(COVID:ORF1ab, frag(\"4393_5324\"))",
          "concept": {
            "name": "ORF1ab",
            "namespace": "COVID"
          },
          "function": "Protein",
          "id": "fd839a98b05d17327ddef0cb687a4b04",
          "variants": [
            {
              "kind": "frag",
              "start": 4393,
              "stop": 5324
            }
          ]
        }
      ]
    },
    {
      "bel": "complex(a(PUBCHEM:89921642), p(COVID:ORF1ab, frag(\"819_2763\")))",
      "function": "Complex",
      "id": "671999ed2ed4d2c6f048608f96aef638",
      "members": [
        {
          "bel": "a(PUBCHEM:89921642)",
          "concept": {
            "name": "89921642",
            "namespace": "PUBCHEM"
          },
          "function": "Abundance",
          "id": "0b66e9d18aa721f07c3f718726f6f911"
        },
        {
          "bel": "p(COVID:ORF1ab, frag(\"819_2763\"))",
          "concept": {
            "name": "ORF1ab",
            "namespace": "COVID"
          },
          "function": "Protein",
          "id": "598b8d5f87bf878c033f8fe9152ffb2b",
          "variants": [
            {
              "kind": "frag",
              "start": 819,
              "stop": 2763
            }
          ]
        }
      ]
    },
    {
      "bel": "p(COVID:ORF1ab)",
      "concept": {
        "name": "ORF1ab",
        "namespace": "COVID"
      },
      "function": "Protein",
      "id": "3e2ae75f3061012cb65ea6b97f7db096"
    },
    {
      "bel": "p(COVID:ORF1ab, frag(\"3264_3569\"))",
      "concept": {
        "name": "ORF1ab",
        "namespace": "COVID"
      },
      "function": "Protein",
      "id": "8b1aed13f6853876f8b68f28deac1a26",
      "variants": [
        {
          "kind": "frag",
          "start": 3264,
          "stop": 3569
        }
      ]
    },
    {
      "bel": "p(COVID:ORF1ab, frag(\"4393_5324\"))",
      "concept": {
        "name": "ORF1ab",
        "namespace": "COVID"
      },
      "function": "Protein",
      "id": "fd839a98b05d17327ddef0cb687a4b04",
      "variants": [
        {
          "kind": "frag",
          "start": 4393,
          "stop": 5324
        }
      ]
    },
    {
      "bel": "p(COVID:ORF1ab, frag(\"5325_5925\"))",
      "concept": {
        "name": "ORF1ab",
        "namespace": "COVID"
      },
      "function": "Protein",
      "id": "99748bbd1c3dda5cfe8a62029f894ba9",
      "variants": [
        {
          "kind": "frag",
          "start": 5325,
          "stop": 5925
        }
      ]
    },
    {
      "bel": "p(COVID:ORF1ab, frag(\"6799_7096\"))",
      "concept": {
        "name": "ORF1ab",
        "namespace": "COVID"
      },
      "function": "Protein",
      "id": "4a61eef55307c856456e953e5ef84207",
      "variants": [
        {
          "kind": "frag",
          "start": 6799,
          "stop": 7096
        }
      ]
    },
    {
      "bel": "p(COVID:ORF1ab, frag(\"819_2763\"))",
      "concept": {
        "name": "ORF1ab",
        "namespace": "COVID"
      },
      "function": "Protein",
      "id": "598b8d5f87bf878c033f8fe9152ffb2b",
      "variants": [
        {
          "kind": "frag",
          "start": 819,
          "stop": 2763
        }
      ]
    },
    {
      "bel": "p(COVID:S)",
      "concept": {
        "name": "S",
        "namespace": "COVID"
      },
      "function": "Protein",
      "id": "8d090715298e11996081058536798c19"
    },
    {
      "bel": "p(HGNC:ACE2)",
      "concept": {
        "name": "ACE2",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "bb9a231a2c68ff8f3bad2adad9ed6a94"
    },
    {
      "bel": "path(DO:\"COVID-19\")",
      "concept": {
        "name": "COVID-19",
        "namespace": "DO"
      },
      "function": "Pathology",
      "id": "6f9f1c2e8012537e503a758c6bfaff0f"
    }
  ]
}